Psychologists in Brandon, SD Accepting Medicare

5 Psychologists found. Showing 1 - 5

Mr. Kyle Babb Psychologist Medicare: Not Enrolled in Medicare Practice Location: 300 S Splitrock Blvd, Brandon, SD 57005 Phone: 605-582-3446    Fax: 605-582-3229

Mrs. Katherine Davidson, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 300 S Splitrock Blvd, Brandon, SD 57005 Phone: 605-582-3446    Fax: 605-582-3229

Mrs. Karlie Renae Maki, ED.S., NCSP Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 300 S Splitrock Blvd, Brandon, SD 57005 Phone: 605-582-2049

Mr. Matthew Reese, ED.S Psychologist Medicare: Not Enrolled in Medicare Practice Location: 300 S Splitrock Blvd, Brandon, SD 57005 Phone: 605-582-3446    Fax: 605-582-3229

Stephanie Sinclair Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 300 S Splitrock Blvd, Brandon, SD 57005 Phone: 605-582-3446

News Archive

NICE issues Final Appraisal Determination for PIXUVRI (pixantrone) drug

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported that the National Institute for Health and Care Excellence (NICE), the independent body responsible for driving improvement and excellence in the health and social care system in the United Kingdom (UK), has issued its Final Appraisal Determination (FAD) for PIXUVRI® (pixantrone).

Roundup: Problems outlined at Parkland hospital in Dallas; Mass. closing a mental hospital; Adult day care in Calif.

The Department of Mental Health plans to close Taunton State Hospital, one of the six state-run psychiatric hospitals in Massachusetts by the end of this year. The move is part of a plan to redistribute the placement of patients with chronic and severe mental illness as a large new state hospital opens in Worcester this summer.

Daiichi Sankyo's Benicar receives FDA approval for hypertension treatment in children and adolescents aged 6-16

Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the hypertension treatment Benicar® (olmesartan medoxomil) for use in children and adolescents 6 to 16 years of age. Benicar was originally approved in 2002 for the treatment of hypertension in adults.

Sectra acquires product rights for Intulo from Krucom

The IT and medical technology company Sectra has acquired the product rights for Intulo, a system that monitors radiation doses, from the Swedish medical IT company Krucom AB.

GM-CSF protein reduces AD pathology, reverses memory loss: Study

A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer's disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease, a new study by the University of South Florida reports. Researchers found that the protein, GM-CSF, likely stimulates the body's natural scavenger cells to attack and remove Alzheimer's amyloid deposits in the brain.

Read more Medical News

› Verified 3 days ago